home / stock / plx / plx news


PLX News and Press, Protalix BioTherapeutics Inc. From 09/11/25

Stock Information

Company Name: Protalix BioTherapeutics Inc.
Stock Symbol: PLX
Market: NYSE
Website: protalix.com

Menu

PLX PLX Quote PLX Short PLX News PLX Articles PLX Message Board
Get PLX Alerts

News, Short Squeeze, Breakout and More Instantly...

PLX - Protalix BioTherapeutics to Present at Investor Summit Virtual

CARMIEL, ISRAEL / ACCESS Newswire / September 11, 2025 / Protalix BioTherapeutics, Inc. (NYSE American:PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx ® plant cell-bas...

PLX - Protalix BioTherapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Protalix BioTherapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference PR Newswire CARMIEL, Israel , Sept. 2, 2025 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American:PLX), a biopharmaceutical company focused on the dev...

PLX - Protalix: Speculative Buy On Promising Plant-Cell Platform And Elfabrio Ramp

2025-08-25 06:57:02 ET ... Read the full article on Seeking Alpha For further details see: Protalix: Speculative Buy On Promising Plant-Cell Platform And Elfabrio Ramp

PLX - Protalix signals $100M+ Elfabrio royalties by 2030 as Phase II PRX-115 trial advances

2025-08-14 12:48:40 ET More on Protalix BioTherapeutics Protalix BioTherapeutics, Inc. (PLX) Q2 2025 Earnings Call Transcript Protalix BioTherapeutics appoints Gilad Mamlok as CFO Seeking Alpha’s Quant Rating on Protalix BioTherapeutics Historical earn...

PLX - Protalix BioTherapeutics, Inc. (PLX) Q2 2025 Earnings Call Transcript

2025-08-14 12:47:54 ET Protalix BioTherapeutics, Inc. (PLX) Q2 2025 Earnings Call August 14, 2025 08:30 A.M. ET Company Participants Dror Bashan - President, CEO & Director Eyal Rubin - Senior VP, CFO, Treasurer & Corporate Secretary Conference Call Par...

PLX - Protalix BioTherapeutics GAAP EPS of $0.00 misses by $0.03, revenue of $15.66M beats by $2.18M

2025-08-14 06:52:50 ET More on Protalix BioTherapeutics Protalix BioTherapeutics appoints Gilad Mamlok as CFO Seeking Alpha’s Quant Rating on Protalix BioTherapeutics Historical earnings data for Protalix BioTherapeutics Financial information for Prota...

PLX - Protalix BioTherapeutics Reports Second Quarter 2025 Financial and Business Results

Protalix BioTherapeutics Reports Second Quarter 2025 Financial and Business Results PR Newswire Company to host conference call and webcast today at 8:30 a.m. EDT CARMIEL, Israel , Aug. 14, 2025 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE Ame...

PLX - Here are the major earnings before the open Thursday

2025-08-13 18:00:29 ET Major earnings expected before the bell on Thursday include: JD.com ( JD ) Deere & Company ( DE ) First Majestic Silver Corp. ( AG ) Tapestry ( TPR ) NetEase ( NTES ) Read the full article on Seeking Alpha Fo...

PLX - Protalix BioTherapeutics Q2 Earnings Preview

2025-08-13 13:11:51 ET More on Protalix BioTherapeutics Protalix BioTherapeutics appoints Gilad Mamlok as CFO Seeking Alpha’s Quant Rating on Protalix BioTherapeutics Historical earnings data for Protalix BioTherapeutics Financial information for Prota...

PLX - Protalix BioTherapeutics to Announce Second Quarter 2025 Financial and Business Results on August 14, 2025

Protalix BioTherapeutics to Announce Second Quarter 2025 Financial and Business Results on August 14, 2025 PR Newswire Company to host conference call and webcast at 8:30 a.m. EDT CARMIEL, Israel , Aug. 7, 2025 /PRNewswire/ -- Protalix BioTherapeutics...

Previous 10 Next 10